与家族性低血型蛋白质血症相关的脂肪性肝病中的当前和新兴问题
Tian-Wen Lou1, Tian-Yi Ren1, Jian-Gao Fan1,2
1Center for Fatty Liver, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Journal of clinical and translational hepatology
|December 31, 2025
概括
由于APOB基因变异引起的家族性低甲蛋白血症 (FHBL) 影响脂蛋白合成和胆固醇水平. 这种情况越来越多地被认为与肝脏疾病有关,为脂肪性肝病机制提供了洞察力.
科学领域:
- 遗传学和分子生物学
- 肝病学 肝病学是一种肝病学.
- 脂质代谢 脂质代谢是什么
背景情况:
- 家庭性低脂蛋白血症 (FHBL) 是由阿波利波蛋白B (APOB) 变体引起的,损害脂蛋白合成并降低胆固醇.
- 虽然异构体通常无症状,但同构体呈现严重症状,包括吸收不良和肝硬化症.
- FHBL正作为脂肪性肝病的单一模型获得关注,与典型的心脏代谢风险因素不同.
研究的目的:
- 审查目前对FHBL的理解,重点关注其遗传基础,临床表现和对肝病的影响.
- 突出FHBL作为研究肥胖性肝病病因的独特模型.
- 确定FHBL研究和管理中的挑战和未来方向.
主要方法:
- 文献综述和对FHBL现有研究的综合.
- 分析APOB中的遗传变异及其功能后果.
- 讨论FHBL相关肝病的拟议病理机制.
主要成果:
- 由于APOB变种,FHBL的特征是血清脂和APOB水平降低.
- 与FHBL相关的肝病的致病机制可能涉及脂质过载,ER压力,氧化损伤和自功能受损.
- 在FHBL诊断,流行病学数据收集和了解疾病进展方面存在重大挑战.
结论:
- FHBL是非心脏代谢性脂肪性肝病的关键模型.
- 改进基因测试和进一步的机械和纵向研究是必不可少的.
- 加强研究对于更好的诊断,风险分层和治疗FHBL相关肝病的治疗策略至关重要.
相关概念视频
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
165
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
165
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Liver Physiology
3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K
Blood Studies for Cardiovascular System III: Serum Lipid Profile
532
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
532
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
197
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
197


